The GLOW Stack is a research blend combining three compounds with distinct but complementary research profiles: GHK-Cu (copper tripeptide), NAD+ (nicotinamide adenine dinucleotide), and PT-141 (Bremelanotide, a melanocortin receptor agonist). This combination represents a convergence of skin biology, mitochondrial energy metabolism, and neuroendocrine signaling โ three axes of considerable interest in longevity and cellular biology research.
This guide reviews the published science behind each component, the mechanistic rationale for their combined investigation, and what researchers need to know about sourcing and handling this blend for in vitro work.
The GLOW Stack is a lyophilized research preparation sold exclusively for in vitro laboratory research purposes. Each component is independently verified to โฅ99% purity before blending. The stack is designed for researchers who want to study the intersecting biology of extracellular matrix maintenance (GHK-Cu), cellular energy and epigenetic regulation (NAD+), and melanocortin receptor pharmacology (PT-141) within a single experimental framework.
Copper tripeptide naturally occurring in human plasma. Researched for collagen synthesis, gene modulation, and antioxidant defense across 50+ years of published studies.
Essential coenzyme for cellular energy, DNA repair, and sirtuin activation. Research implicates NAD+ decline in aging biology and metabolic dysfunction.
Bremelanotide โ cyclic heptapeptide MC receptor agonist. Researched for MC1R/MC3R/MC4R pharmacology and neuroendocrine signaling pathways.
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is the cornerstone of the GLOW stack's skin biology research applications. Discovered in 1973, this naturally occurring tripeptide is present in human plasma at concentrations that decline sharply with age โ from approximately 200 ng/mL at age 20 to under 80 ng/mL by age 60. This age-dependent decline has made it a primary subject of skin aging and longevity research.
A landmark microarray study found that GHK-Cu modulated the expression of more than 4,000 human genes โ including antioxidant defense systems (SOD, catalase, glutathione peroxidase), DNA repair pathways, mitochondrial function genes, and anti-inflammatory regulators. In aged tissue models, GHK-Cu partially reversed the gene expression signature of aged cells toward a more youthful pattern. This broad epigenetic-adjacent activity makes GHK-Cu a uniquely interesting companion to NAD+ in multi-compound longevity research.
Nicotinamide adenine dinucleotide (NAD+) is one of the most fundamental coenzymes in cellular biology. Present in every living cell, it serves as an electron carrier in metabolic reactions and as a substrate for key regulatory enzymes. NAD+ levels decline significantly with age โ up to 50% reduction in some tissues by middle age โ making it a central target of longevity research.
The GLOW stack's combination of GHK-Cu and NAD+ is particularly interesting from a skin biology standpoint. Keratinocytes and dermal fibroblasts โ the primary cell types of skin โ are both highly dependent on NAD+ for energy metabolism and DNA repair. Research suggests that NAD+ decline contributes to reduced cellular repair capacity in aged skin, while GHK-Cu addresses the structural and gene-regulatory aspects. Together, these two components may support investigation of multiple aging-related axes in the same in vitro model.
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide derived from Melanotan II. Unlike the linear structure of ฮฑ-MSH, PT-141's lactam bridge confers resistance to enzymatic degradation, making it a more stable research tool for melanocortin receptor biology.
The inclusion of PT-141 in the GLOW stack creates an interesting three-way intersection with the skin biology applications of GHK-Cu. MC1R is expressed on melanocytes, keratinocytes, and dermal fibroblasts, and its activation has been studied for effects on UV response, DNA repair activation (through the MITF-MC1R axis), and melanin synthesis regulation. Researchers studying skin cell biology may find the MC1R agonism of PT-141 complementary to the ECM effects of GHK-Cu.
The three GLOW components address distinct cellular systems with overlapping relevance to longevity and skin biology research:
No two components share primary mechanisms, making GLOW suitable for researchers investigating how these parallel biological axes interact โ for example, whether NAD+-dependent epigenetic regulation interacts with GHK-Cu's gene expression effects, or how MC1R activation in skin cells modulates the collagen synthesis response to copper peptide signaling.
BPC-157 + TB-500 + GHK-Cu ยท Third-party HPLC/MS verified ยท US domestic shipping 24โ48h
View GLOW Stack โEach GLOW component is also available as a standalone research compound for single-compound controls:
For researchers focused on skin repair and tissue healing biology rather than neuroendocrine pathways, the KLOW Stack (BPC-157 + TB-500 + GHK-Cu + KPV) may be a complementary preparation โ it adds KPV for gut barrier and anti-inflammatory signaling alongside the shared BPC-157, TB-500, and GHK-Cu components.
Research Use Only: GLOW Stack is sold strictly for in vitro laboratory research. Not for human consumption, veterinary use, or clinical application. These statements have not been evaluated by the FDA.